Culturally Adapted Group Cognitive Behavior Therapy (CaGCBT-SUDs) for Substance Use Disorders and Their Caregivers
CaGCBT-SUDs
Effectiveness of Culturally Adapted Group Cognitive Behavior Therapy on Adults With Substance Use Disorders and Their Caregivers: A Randomized Control Trial From Pakistan
1 other identifier
interventional
30
1 country
5
Brief Summary
Pakistan is facing a massive rise in drug abuse. According to recent estimates, there are 6.7 million drug abusers, of which 4.25 million are drug dependents who need long-term treatments in residential setups. Despite these shocking statistics, there is a severe lack of evidence-based treatment, preventive measures, and drug indictment policies. Consequently, the number of drug dependents continues to increase at an alarming rate of 40,000 per year, making Pakistan one of the most drug-affected countries in the world. The ever-increasing rise in drug abuse can be devastating for a country such as Pakistan where the youth population (aged \<30 years) makes up a substantial 64% of the total population. It not only affects the individual's physical and mental health but also casts devastating effects on the psycho-social and economic aspects of their lives. Adults with Substance Use Disorders (SUDs) usually come across aggravated interpersonal and family problems, loss of productivity and unemployment, poverty and crimes, overall financial problems, deaths, and accidents. Furthermore, it also destroys the norms, morality, worth, and dignity of the person's well-being and effectiveness in the growth of society. Numerous studies in Pakistan showed a lack of evidence-based treatment altogether for adults suffering from SUDs. Thus, effective interventions for SUDs that also meet the clinical reality of open treatment groups are much needed to reduce the treatment gap. Further, the implementation of evidence-based approaches like Cognitive Behavior Therapy (CBT) has an advantage with SUDs clients who are motivated. The proposed project aims at the cultural adaptation of CBT-based group intervention for adults with substance use disorders (SUDs) in Pakistan by employing a Quasi-Experimental research design, followed by Randomized Control Trials to test its effectiveness in Pakistan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2022
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 21, 2022
CompletedFirst Submitted
Initial submission to the registry
June 3, 2024
CompletedFirst Posted
Study publicly available on registry
June 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJune 17, 2025
June 1, 2025
1.5 years
June 3, 2024
June 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Addiction Severity Index-Lite Version
The ASI covers the following areas: medical, employment/support, drug and alcohol use, legal, family/social, and psychiatric. The ASI obtains lifetime information about problem behaviors, as well as problems within the previous 30 days. The ASI-Lite contains 22 fewer questions than the ASI, and omits items relating to severity ratings, and a family history grid. The higher a subject scores on the ASI, the greater the indication of a need for treatment.
Upto 8-12 weeks
Revised Mental Health Inventory- 5
The MHI-5 was developed for its use with the general population, and it includes items on psychological well-being. The total score ranges from 0 to 15, with higher scores indicating better mental health.
Upto 8-12 weeks
The Readiness to Change Questionnaire
designed to assess stages of change in substance abusers, in terms of the Prochaska and DiClemente stages of change model. The score ranges for each scale is -10 through 0 to +10. Score towards positive end indicates patients' readiness to change.
Upto 8-12 weeks
Secondary Outcomes (5)
Relapse Risk Scale
Upto 8-12 weeks
Coping Strategies Scale
Upto 8-12 weeks
WHO Quality of Life- Brief version
Upto 8-12 weeks
Subjective Well-being Scale
Upto 8-12 weeks
Family Burden Interview Schedule
Upto 8-12 weeks
Study Arms (3)
CaGCBT with TAU
EXPERIMENTALIn this group, CaGCBT-SUD along with TAU will be provided.
CBTAG with TAU and with caregivers
ACTIVE COMPARATORIn this group, CaGCBT-SUD along with TAU will be provided. Moreover caregivers will be provided psychoeducation
No intervention only TAU
NO INTERVENTIONTreatment as usual
Interventions
In first session, introduction of the therapist/facilitator and group members will be made. Group rules will be discussed with members. Group members' introduction primarily focuses on participant/clients' expectations, addictive behaviors and its status, and goals. Moreover, it also emphasize on identification of any other significant issue that is contributing in burden of disease.
Eligibility Criteria
You may qualify if:
- Diagnosed individuals with substance use disorder within the age bracket of 18-64 years.
- In-patient of rehabilitation center and detoxified for 2 months
- Able to give written informed consent
- Able to read and speak Urdu
You may not qualify if:
- Presence of a diagnosed physical or intellectual disability as it can prevent individuals from engaging with the intervention. This will be assessed by the research team at screening stage. Any disabilities will be identified by a relevant clinician (e.g., Psychiatrist).
- Temporary resident unlikely to be available for follow-up
- Being detoxified less than 2 months
- Individuals with substance use disorder having follow up with rehabilitation center
- Having Comorbidity with psychological disturbances like depression, anxiety etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
BMC Psychiatry
Quetta, Balochistan, 87300, Pakistan
ANF rehabilitation Centre
Islamabad, Islamabad, 45000, Pakistan
Dr. Mian Iftekhar Psychiatry Hospital
Peshawar, KPK, 25000, Pakistan
Life Care International Hospital
Lahore, Punjab Province, 05450, Pakistan
Parwarish Rehabilitation centre
Karachi, Sindh, 05444, Pakistan
Study Officials
- PRINCIPAL INVESTIGATOR
Anila Sadaf, PhD
NUML
- STUDY DIRECTOR
Rizwana Amin
Bahria University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2024
First Posted
June 17, 2024
Study Start
December 21, 2022
Primary Completion
June 30, 2024
Study Completion
December 31, 2024
Last Updated
June 17, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share